Using Biomarkers for Advanced Head and Neck Cancer to Individualize Treatment Decision-Making
Using Biomarkers for Advanced Head and Neck Cancer to Individualize Treatment Decision-Making is organized by Prime Education, LLC.
Release Date: March 31, 2023
Expiration Date: March 30, 2024
Description:
Biomarkers play an increasingly important role in therapy selection for patients with head and neck cancers. You can test your skills in biomarker and therapy selection in this clinical case challenge from the Head and Neck Cancer Learning Lab. See how you stack up against your peers as you consider testing and treatment strategies.
This activity is part of a series, case managers must complete all activities in this learning lab before reporting credit to the Commission for Case Manager Certification using the activity code and approval number issued upon completion. Visit the Head and Neck Cancer learning Lab(opens in a new tab) to complete the other activities.
Agenda:
• Biomarker Testing for a Patient With Advanced Head and Neck Cancer
• Using Current Clinical Evidence and Biomarkers to Guide Treatment Decision-Making in Head and Neck Cancer
Learning Objectives:
• Describe evidence-based practices for using PD-L1, p16, microsatellite instability, and other emerging biomarkers to select candidates for immunotherapy
• Align clinical practices with current clinical data and guidelines for treatment selection based on patient-, disease-, and treatment-specific factors
Additional details will be posted as soon as information is available.